Biotechnology

Gainers Avis Budget Group, Inc. (NASDAQ: CAR) surged 83.9% to $315.37 after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback. The OLB Group, Inc. (NASDAQ: OLB) shares climbed 76.9% to $8.12 after the company announced support for...

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has signed a collaboration agreement with Double-Crane Pharmaceutical Co Ltd (CRDC). The agreement grants CRDC exclusive Asia territorial rights to develop an oral COVID-19 antiviral using Ligand's BEPro technology....

  Evercore ISI Group raised Lear Corporation (NYSE: LEA) price target from $170 to $220. Lear shares fell 0.3% to close at $167.76 on Monday. Wells Fargo lowered the price target on QUALCOMM Incorporated (NASDAQ: QCOM) from $155 to $138. QUALCOMM shares rose 0.3% to $125.27 in pre-market...

Turning Point Therapeutics Inc (NASDAQ: TPTX) announced early data from TRIDENT-1 Phase 1/2 study of its lead drug candidate repotrectinib. In the NTRK-positive TKI-naïve advanced solid tumor population (n=17), the confirmed Objective Response Rate (cORR) was 41%.  Three...

Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking. Merus N.V. (NASDAQ: MRUS) jumped 37.5% to close at $27.49 as the company presented early clinical...

Gainers Camber Energy, Inc.. (NYSE: CEI) jumped 44.2% to $1.3102 after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking. Paltalk, Inc. (NASDAQ: PALT) shares jumped 40.1% to $9.71 after dropping over 15% on Wednesday. Paltalk’s recent filing...

Turning Point Therapeutics Inc (NASDAQ: TPTX) has announced additional preliminary data from ongoing trials of lead drug candidate repotrectinib and elzovantinib (TPX-0022).  The data were presented at the Virtual International Conference on Molecular Targets and Cancer...

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has presented additional analyses from SOLOIST and SCORED Phase 3 trials evaluating heart failure candidate sotagliflozin, a dual SGLT1 & SGLT2 inhibitor. Data were presented at the ESC Congress 2021 - The Digital Experience.  In...

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers. Lightning eMotors, Inc. (NYSE: ZEV) shares climbed 81% to settle at $11.60 after the...

Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a definitive agreement whereby Penn National will acquire Score Media and Gaming for approximately $2.0 billion in cash and...

Gainers IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger deal with TeraWulf. Alpha Teknova, Inc. (NASDAQ: TKNO) gained 56.3% to settle at $25.00 after the company priced its IPO at $16 a share. Grove, Inc. (NASDAQ: GRVI)...

The FDA has granted Orphan Drug Designation to Turning Point Therapeutics Inc's (NASDAQ: TPTX) TPX-0022, for gastric cancer, including gastroesophageal junction adenocarcinoma. TPX-0022 is a potent inhibitor of the MET tyrosine kinase, and currently, there are no approved...

Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14.88 in pre-market trading. Workhorse Group shares surged around 20% on Wednesday amid strength in EV names as well as...